Zhang Y, Wang L, Gao P, Sun Z, Li N, Lu Y, et al. ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells. Int J Mol Med. 2018;42:2343-2352 pubmed publisher